Increased risk of venous thromboembolism (VTE) and shorter survival in neuroendocrine versus castration-resistant prostate cancer
Thrombosis Research(2018)
摘要
Introduction: Neuroendocrine prostate cancer (NEPC) is an aggressive form of PC thought by clinicians to carry a higher risk of VTE than standard castration-resistant prostate cancer (CRPC) though it is unclear if this is due to propensity for visceral metastasis or receipt of platinum chemotherapy. We previously reported differences in gene expression of procoagulant factors at ICTHIC 2016, with significantly higher prothrombin expression in NEPC. Here we present our clinical experience of venous thromboembolism events (VTE) in a cohort of NEPC and CRPC patients.
更多查看译文
关键词
Venous Thromboembolism,Prostate Cancer,Metastatic Prostate Cancer
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要